Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
1,274 total articles
Millicom International Cellular S.A. (Nasdaq: TIGO) convenes its Annual General Meeting (AGM) for May 20, 2026, in Luxembourg. The AGM agenda includes approval of 2025 financials, distribution of a $3 per share annual dividend payable in four installments during 2026-2027, re-election of all eight board members, approval of directors' remuneration,…
FibroBiologics, a clinical-stage biotechnology company, announced a Board-approved 1-for-20 reverse stock split effective March 30, 2026, aimed at regaining compliance with Nasdaq's minimum bid price requirement. The reverse split reduces the number of outstanding shares significantly while maintaining the existing authorized share count and does n…
Glacier Bancorp, Inc. announced a quarterly dividend of $0.33 per share, continuing its track record of 164 consecutive quarterly dividends and 49 increases in the dividend amount. This signals the company's strong financial health and commitment to returning value to shareholders, with dividends payable on April 16, 2026.
Apollo Global Management has priced an offering of $750 million aggregate principal amount of 5.700% Senior Notes due 2036. The proceeds will be used for general corporate purposes, including repaying the $500 million 4.400% Senior Notes due 2026, and related fees. The offering is expected to close on March 30, 2026, and is managed by major financi…
BeyondSpring Inc., a clinical-stage biopharmaceutical company focused on developing novel cancer therapies, announced the filing of its 2025 annual report on Form 10-K with the SEC. The report includes audited consolidated financial statements and details about its pipeline, including the late-stage clinical asset Plinabulin targeting non-small cel…
Dime Community Bancshares, a New York State-chartered trust company with $15 billion in assets and a leading deposit market share on Long Island, announced a quarterly cash dividend of $0.25 per common share payable on April 24, 2026. This continues the company's trend of uninterrupted dividends, highlighting financial stability and shareholder val…
Serina Therapeutics reported full year 2025 financial results, highlighting FDA clearance of IND application and initiation of Phase 1b trial for SER-252 targeting advanced Parkinson's disease. The company also closed a private placement financing up to $30 million, enhancing its financial position to support clinical progress. R&D and operating ex…
Exicure, Inc. disclosed its full-year 2025 financial results, reporting a net loss of $4.9 million, an improvement from $9.7 million in 2024 primarily due to a $6 million gain from early lease termination. The company incurred increased R&D and administrative expenses following its acquisition of GPCR Therapeutics USA Inc. It ended 2025 with $3.7 m…
Emergent BioSolutions announced a $54 million contract award with the U.S. government and $6.6 million in new orders from an international government partner to supply smallpox medical countermeasures CNJ-016® and ACAM2000®. These contracts support biodefense and public health preparedness efforts against smallpox and other biological threats, foll…
Scorpio Tankers Inc. announced updates on its average daily Time Charter Equivalent (TCE) rates for the first and second quarters of 2026, showing strong contract coverage and increased rates in core vessel segments. The company also provided details on its liquidity and outstanding debt, highlighting significant net cash position and expected proc…
ONEOK, Inc., a leading midstream energy infrastructure company, announced that directors Gerald B. Smith and Pattye L. Moore will retire from the board at the upcoming 2026 Annual Meeting of Shareholders. Smith is retiring due to the mandatory retirement age policy, while Moore has chosen to retire voluntarily. Both have contributed significantly t…
Hallador Energy Company announced a three-year agreement to sell nearly all its remaining accredited capacity from 2026 to 2028 at approximately double the currently embedded capacity prices, expected to generate $86 million in cumulative revenue and significantly boost future cash flow from its Merom Generating Station. The company also highlighte…
CaliberCos Inc. (Nasdaq: CWD), a diversified real estate and digital asset management platform, reported a platform net loss of $7.7 million for Q4 2025, an improvement from last year, driven by asset management revenues of $4.0 million and impacted by unrealized losses in digital assets. Full-year 2025 platform revenue declined to $15.2 million fr…
ARMOUR Residential REIT, Inc. has provided guidance for its April 2026 dividend on its common stock at $0.24 per share. The dividend will be paid on April 29, 2026, to holders of record as of April 15, 2026. The company maintains its tax status as a REIT and emphasizes that actual dividends are subject to board discretion based on company performan…
Colombier Acquisition Corp. III announced that starting March 27, 2026, holders of its previously issued units from the IPO can opt to trade Class A ordinary shares and warrants separately on the NYSE under the tickers CLBR and CLBR WS, respectively. Units not separated will continue trading under CLBR U. The company is a blank check firm seeking f…
Omega Flex, Inc., listed on NASDAQ under ticker OFLX, announced a regular quarterly dividend of $0.34 per share for the first quarter of 2026. The dividend will be payable on April 21, 2026 to shareholders of record on April 9, 2026. The company's Board of Directors will continue to evaluate quarterly dividend amounts based on financial performance…
Lifeward Ltd. has completed its strategic partnership with Oramed Pharmaceuticals, acquiring Oramed's clinical-stage Protein Oral Delivery technology and gaining access to up to $47 million in capital. This partnership diversifies Lifeward's biomedical innovation portfolio and positions the company on a clear path to profitability, while also leadi…
Regeneron Pharmaceuticals, a leading biotechnology company, announced it will report its Q1 2026 financial and operating results on April 29, 2026, prior to U.S. market open. A conference call and webcast will be held to discuss these results.
Workhorse Group Inc. announced a new configuration of its W56 step van featuring a 140 kWh battery, designed specifically for urban last-mile delivery routes. The new model offers a 100-mile range at a lower entry price starting at $169,000, responding to customer demand for cost-effective EVs to diversify fleets and hedge against rising fuel costs…
Prairie Operating Co., a US-based independent energy company focused on oil and natural gas development in the Denver-Julesburg Basin, announced that the anniversary warrant issuance date tied to its Series F Convertible Preferred Stock has been extended from March 26, 2026 to April 7, 2026. This extension allows additional time for ongoing discuss…
Rigetti Computing announced plans to invest up to $100 million in the UK to accelerate quantum computing development, aiming to deploy a quantum computer with over 1,000 qubits within 3 to 4 years. This marks Rigetti's first major investment outside the US and aligns with the UK government's £2 billion quantum computing initiative. The company high…
Minerva Neurosciences announced data from its open-label safety trial evaluating the co-administration of roluperidone and olanzapine. The study showed no significant safety, pharmacokinetic, or pharmacodynamic issues, supporting continued development. The company is now enrolling a confirmatory Phase 3 trial with topline data expected in the secon…
Firefly Aerospace, a U.S.-based space and defense technology company, supported Lockheed Martin and the U.S. Space Force in the VICTUS DIEM exercises focusing on rapid spacecraft processing and launch capabilities. The exercises demonstrated spacecraft arrival, integration, and launch operations within stringent timelines under simulated threat con…
Outlook Therapeutics, a U.S.-based biopharmaceutical company focused on ophthalmic treatments for retina diseases, successfully closed a $5.0 million public offering by selling 20 million common shares with accompanying warrants. The funds raised will primarily support working capital and general corporate activities. The company is developing LYTE…
WidePoint Corporation reported fourth quarter and full year 2025 results showing revenue growth compared to the prior year. The company achieved its 34th consecutive quarter of positive adjusted EBITDA and 9th quarter of positive free cash flow. Significant contract wins and backlog totaling over $220 million position WidePoint for future growth, p…
